Reuters logo
Novabay Pharma sees IPO of 5 mln shares at $4-$6 each
August 10, 2007 / 6:02 PM / 10 years ago

Novabay Pharma sees IPO of 5 mln shares at $4-$6 each

Aug 10 (Reuters) - Novabay Pharmaceuticals Inc. on Friday filed for an initial public offering of 5 million shares at an estimated price of $4 to $6 per share.

The biopharmaceutical company said Dundee Securities Inc. and Blackmont Capital Corp., among others, are underwriting the IPO, according to a filing with the U.S. Securities and Exchange Commission.

The Emeryville, California-based company said it applied for an American Stock Exchange listing under the symbol “NBY.” (Reporting by Sayantani Ghosh in Bangalore)

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below